Lagis Enterprise Co., Ltd. (6730) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Lagis Enterprise Co., Ltd. (6730:TWSE), powered by AI.

Current Price
$35.75
P/E Ratio
16.8
Market Cap
1.1B
Sector
Healthcare
What is the Lagis Enterprise Co., Ltd. stock price forecast?

Lagis Enterprise Co., Ltd. is currently trading at $35.75. View real-time AI analysis on Alpha Lenz.

What is Lagis Enterprise Co., Ltd. insider trading activity?

View the latest insider trading data for Lagis Enterprise Co., Ltd. on Alpha Lenz.

What is Lagis Enterprise Co., Ltd.'s P/E ratio?

Lagis Enterprise Co., Ltd.'s P/E ratio is 16.8.

Lagis Enterprise Co., Ltd.

NT$35.75
TWSE6730
Ask about Lagis Enterprise Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Lagis Enterprise Co., Ltd. trades at a P/E of 16.8 (fair value) with solid ROE of 12.2%.

Ask for details

Company Overview

Lagis Enterprise Co., Ltd. is a Taiwan-based manufacturer specializing in medical equipment within the healthcare sector. The company focuses on designing, patenting, and marketing devices essential for laparoscopic and endoscopic surgeries, supplying products such as suction and infusion pumps, cutting and electrosurgical instruments, retractors, powered tools, and various grasping or grafting instruments. Its primary function is to deliver advanced, minimally invasive surgical solutions used by hospitals and clinics worldwide, helping improve outcomes across diverse medical procedures. Lagis Enterprise’s product portfolio serves the broader health technology and medical specialties industries, supporting the global trend toward less invasive treatment modalities. With steady revenue growth and a market capitalization in the mid-1 billion TWD range, the company has maintained a notable presence in its market, distributing products internationally with significant sales in Japan, Taiwan, and other regions. Lagis Enterprise plays an important role in advancing surgical technology and supporting healthcare providers' needs for reliable, innovative equipment.

CEOMr. Zhenghong Chen
SectorHealthcare
IndustryMedical Instruments & Supplies
0

Company Statistics

(FY 2024)

Profile

Market CapNT$1.14B
RevenueNT$454.36M
Shares Out0.00
Employees0

Margins

Gross48.73%
EBITDA25.74%
Operating17.87%
Pre-Tax18.77%
Net15.02%

Valuation

P/E16.77
P/B1.97
EV/Sales2.52
EV/EBITDA12.56
P/FCF-5.66

Growth (CAGR)

Rev 3Yr4.95%
Rev 5Yr2.25%
Op Inc 3Yr7.81%
Op Inc 5Yr-6.28%
Net Inc 3Yr11.72%
Net Inc 5Yr-5.21%

Returns

ROA7.07%
ROE12.18%
ROIC8.84%

Financial Health

Cash & Cash EquivalentsNT$69.20M
Net DebtNT$437.14M
Debt/Equity87.33%
Interest CovN/A
Ask Alpha Chat

Frequently Asked Questions

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Lagis Enterprise Co., Ltd. (Healthcare) Stock Forecast & Analysis $35.75 | Alpha Lenz